The Trial to Assess Chelation Therapy, sponsored by the National Institutes of Health, was the first controlled study of EDTA chelation therapy. Until the results were released, many traditional cardiologists had pooh-poohed chelation therapy as a bogus procedure. Some refused to treat cardiac patients who chose to have chelation therapy. They expected the chelation study to prove chelation worthless. They were wrong. According to the actual literature, intravenous chelation therapy reduces heart attacks by 40% in diabetics, and reduces their mortality by 50%. These are amazing figures!
Diabetics are at high risk for cardiovascular disease, including heart attacks, strokes and congestive heart failure. Diabetes is considered equivalent to pre-existing heart disease as a risk factor for new events.
Chelation therapy removes heavy metals from the body for excretion in the urine. Lead and cadmium are heavy metals that contribute to blood vessel degeneration, and may remain in body tissues for many years. Chelation therapy speeds up the process of metal removal.
Other parts of a complete intravenous chelation treatment are vitamin C, magnesium, calcium, B vitamins, trace minerals, procaine and low dose heparin. These ingredients may also enhance detoxification and protect blood vessels from damage.
Intravenous EDTA chelation therapy takes about three hours. A total of thirty to forty treatments given one to three times a week constitutes a full program. We often continue treatments once a month thereafter, to maintain the benefits.
People with diabetes or pre-diabetes, especially those who have already endured a heart attack, bypass surgery or stent placement should strongly consider adding chelation therapy to their treatment regimen.
If you would like assistance in controlling diabetes or cardiovascular disease, we can help. IPM offers a full array of alternative and traditional therapies for these conditions and many others. Call us at (949) 600-5100 to make an appointment today.